Z-1390-2016 Class III Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-1390-2016 was initiated by Becton, Dickinson And Company, BD Biosciences on Mar 18, 2016 and is designated Class III. Reason for recall: The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct. The recall status is terminated (terminated Dec 2, 2016). Affected quantity: 205.

Recall details

Product Type
Devices
Report Date
Apr 20, 2016
Initiation Date
Mar 18, 2016
Termination Date
Dec 2, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
205

Product description

BD-Retic-Count Reticulocyte Reagent System; Hematology: Used for in vitro diagnostics

Reason for recall

The carton label for one lot of BD Retic-Count Reticulocyte Reagent System had the incorrect storage conditions. The labels on the reagent as well as the Instructions for Use are correct.

Distribution pattern

Worldwide Distribution - US Distribution to the states of : CT, MN, FL, NY, CA, MA, DC, UT, VA and IN., and to the countries of : Belgium, Brazil, Canada, China, India, Japan, Korea, Singapore and Taiwan.

Code information

Product number 349214, Lot number 5175559, Expiry 5/31/16.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1390-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1390-2016. Report a data issue: hello@regdatalab.com.